ConductScience.org, home

Trial · NCT01905683

Adverse events19

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherNasopharyngitisInfections and infestations16 - 20 U/kg Body Weight IncobotulinumtoxinA (Xeomin)2037034
seriousTenotomySurgical and medical procedures16 - 20 U/kg Body Weight IncobotulinumtoxinA (Xeomin)23703
seriousCast applicationSurgical and medical procedures16 - 20 U/kg Body Weight IncobotulinumtoxinA (Xeomin)13701
seriousArrhythmiaCardiac disorders16 - 20 U/kg Body Weight IncobotulinumtoxinA (Xeomin)13701
seriousEpilepsyNervous system disorders16 - 20 U/kg Body Weight IncobotulinumtoxinA (Xeomin)23702
seriousClonic convulsionNervous system disorders16 - 20 U/kg Body Weight IncobotulinumtoxinA (Xeomin)13701
seriousFebrile convulsionNervous system disorders16 - 20 U/kg Body Weight IncobotulinumtoxinA (Xeomin)13701
seriousSeizureNervous system disorders16 - 20 U/kg Body Weight IncobotulinumtoxinA (Xeomin)13704
seriousGastritisGastrointestinal disorders16 - 20 U/kg Body Weight IncobotulinumtoxinA (Xeomin)13701
seriousGastroenteritisInfections and infestations16 - 20 U/kg Body Weight IncobotulinumtoxinA (Xeomin)33704
seriousBronchitisInfections and infestations16 - 20 U/kg Body Weight IncobotulinumtoxinA (Xeomin)23703
seriousAdenoiditisInfections and infestations16 - 20 U/kg Body Weight IncobotulinumtoxinA (Xeomin)13701
seriousAdenovirus infectionInfections and infestations16 - 20 U/kg Body Weight IncobotulinumtoxinA (Xeomin)13702
seriousCroup infectiousInfections and infestations16 - 20 U/kg Body Weight IncobotulinumtoxinA (Xeomin)13701
seriousNasopharyngitisInfections and infestations16 - 20 U/kg Body Weight IncobotulinumtoxinA (Xeomin)13701
seriousEnteritis infectiousInfections and infestations16 - 20 U/kg Body Weight IncobotulinumtoxinA (Xeomin)13701
seriousRespiratory tract infection viralInfections and infestations16 - 20 U/kg Body Weight IncobotulinumtoxinA (Xeomin)13701
seriousHemagglutinin Type 1 and Neuraminidase Type 1 (H1N1) influenzaInfections and infestations16 - 20 U/kg Body Weight IncobotulinumtoxinA (Xeomin)13701
seriousPneumoniaInfections and infestations16 - 20 U/kg Body Weight IncobotulinumtoxinA (Xeomin)13701

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01905683/events